David Wallace and Timothy Stocksdale co-founded Arriva Medical in Coral Springs, Fla. After its sale to diagnostic testing company Alere in Waltham, Mass., Mr. Wallace and Mr. Stocksdale remained on as Arriva’s president and vice president, respectively, from 2011-13.
The settlement, reached in the Middle District of Tennessee, settled allegations that the former executives caused Arriva to submit false claims to Medicare. The claims, according to prosecutors, involved monetary kickbacks to beneficiaries, such as free or no-cost home blood glucose meters. They also waived or didn’t collect copayments from 2011-13, according to the Justice Department. The settlement also resolves accusations that the former executives caused Arriva to bill Medicare for medically unnecessary home blood glucose meters.
In 2016, CMS revoked Arriva’s Medicare billing privileges for durable medical equipment after it shipped goods to a beneficiary more than 14 days after their death. Arriva stopped operating in late 2017.
More articles on legal and regulatory issues:
15 latest healthcare industry lawsuits, settlements
Pharmacy tech gets prison sentence for stealing $100K worth of supplies
Tulare hospital district accuses ex-board members, legal council of breaching fiduciary duties
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
